StonvexLoading…
StonvexStonvexStonvexCore line items from LRHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|
Revenue | $69.45M | $31.76M |
Operating Income | $-11.20M | $-7.09M |
Net Income | $-14.45M | $-7.82M |
EPS (Diluted) | $-0.79 | $-1.27 |
Total Assets | $19.41M | $14.33M |
Total Liabilities | $12.73M | $4.56M |
Cash & Equivalents | $1.44M | $959.60K |
Free Cash Flow OCF − CapEx | $-3.00M | Not available |
Shares Outstanding | 21.85M | 13.41M |